Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rational targeting for prion therapeutics.

Giovanna Mallucci1, John Collinge

  • 1Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.

Nature Reviews. Neuroscience
|December 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

A scalable, dividing cell model for the robust propagation and quantification of human sporadic Creutzfeldt-Jakob disease prions.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Strain-specific propagation of variant Creutzfeldt-Jakob disease prions in humanized neural cells.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Prion propagation is controlled by discrete structural regions of PrP rather than overall stability.

The Journal of biological chemistry·2026
Same author

Modification of early behavioural, physiological and neuropathological endpoints by syntaxin-6 knockout in a humanised P301S transgenic model of tauopathy.

Acta neuropathologica·2026
Same author

High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure.

JAMA neurology·2026

Researchers halted prion disease progression and reversed early pathology in mice by targeting the cellular prion protein. This offers optimism for developing therapeutics against fatal prion neurodegeneration.

Area of Science:

  • Neuroscience
  • Pathobiology
  • Prion Disease Research

Background:

  • Prions are lethal pathogens, believed to be conformational isomers of the cellular prion protein.
  • Prion-like mechanisms may have broader pathobiological significance, driving research into neurodegeneration.
  • Concerns about bovine spongiform encephalopathy (BSE) transmission to humans, causing variant Creutzfeldt-Jakob disease (vCJD), highlight the need for therapeutics.

Purpose of the Study:

  • To investigate therapeutic strategies for interrupting aggressive and fatal prion neurodegenerative diseases.
  • To explore the potential of targeting the cellular prion protein as a therapeutic approach.

Main Methods:

  • Utilized a mouse model of established neuroinvasive prion infection.
  • Focused therapeutic interventions on the cellular prion protein rather than prions directly.

Related Experiment Videos

Main Results:

  • Successfully halted the onset of clinical disease in the prion-infected mouse model.
  • Demonstrated reversal of early prion disease pathology.
  • Indicated that the cellular prion protein, not prions themselves, may be a more effective therapeutic target.

Conclusions:

  • Halting disease progression and reversing pathology in a prion infection model is achievable.
  • Targeting the cellular prion protein presents a promising therapeutic avenue for prion diseases.
  • Findings offer considerable optimism for developing effective treatments for fatal neurodegenerative prion conditions.